{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T13:45:18Z","timestamp":1780321518169,"version":"3.54.1"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:00:00Z","timestamp":1722988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Colitis Crohn\u2019s Association"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background and Aims<\/jats:title>\n                  <jats:p>There are few studies on the cost-effectiveness of telemedicine for inflammatory bowel diseases. We assessed the long-term cost-effectiveness of a telemedicine solution compared to standard care (sCare), as well as its efficacy according to patient-reported outcomes (PROs).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Between 2015 and 2020, we conducted a retrospective, register-based study among patients with ulcerative colitis and Crohn\u2019s disease. Direct and indirect healthcare costs over a 5-year period were obtained from Danish registers and compared to a control group. Costs were estimated on a yearly basis from 1 year before, until 5 years after, inclusion in the trial. Patients were divided into 2 groups: those not receiving biologics (Cohort 1) and those receiving biologics (Cohort 2).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We recruited 574 patients with inflammatory bowel diseases. In Cohort 1 (61.5%), average total direct costs and total earnings per patient per year were \u20ac14\u00a0043 and \u20ac307\u00a0793, respectively, in telemedicine compared to \u20ac16\u00a0226 and \u20ac252\u00a0166, respectively, in sCare. In Cohort 2 (38.5%), average total direct costs and total earnings were \u20ac73\u00a0916 and \u20ac215\u00a0833, respectively, in telemedicine compared to \u20ac41\u00a0748 and \u20ac203\u00a0667, respectively, in sCare. PROs showed improved quality of life, which was higher in Cohort 1 than in Cohort 2. Disease activity among patients with Crohn\u2019s disease increased after Years 3 and 4 in Cohorts 1 and 2, respectively.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Telemedicine is cost-effective for patients not receiving biologics. However, treatment with biologics is more expensive for patients enrolled in telemedicine. Careful attention to PROs in telemedicine improves quality of life and could prolong the time to relapse.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ecco-jcc\/jjae120","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:14:22Z","timestamp":1723076062000},"source":"Crossref","is-referenced-by-count":6,"title":["The Costs of Home Monitoring by Telemedicine vs Standard Care for Inflammatory Bowel Diseases\u2014A Danish Register-Based, 5-Year Follow-up Study"],"prefix":"10.1093","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8642-3076","authenticated-orcid":false,"given":"Marwah","family":"Al-Sheikh","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Medical Division, Copenhagen University Hospital , North Zealand ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorit Vedel","family":"Ankersen","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Medical Division, Copenhagen University Hospital , North Zealand ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Olsen","sequence":"additional","affiliation":[{"name":"EY b , Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Spanggaard","sequence":"additional","affiliation":[{"name":"EY b , Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte T","family":"Peters-Lehm","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Medical Division, Copenhagen University Hospital , North Zealand ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahim M","family":"Naimi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Medical Division, Copenhagen University Hospital , North Zealand ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette","family":"Bennedsen","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Medical Division, Copenhagen University Hospital , North Zealand ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3312-5139","authenticated-orcid":false,"given":"Johan","family":"Burisch","sequence":"additional","affiliation":[{"name":"Gastro Unit, Medical Division, Copenhagen University Hospital \u2013 Amager and Hvidovre , Hvidovre ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Munkholm","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Medical Division, Copenhagen University Hospital , North Zealand ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,8,7]]},"reference":[{"key":"2025021912242247100_CIT0001","first-page":"85","article-title":"Telemonitoring and self-care in patients with IBD.","volume-title":"Telemanagement of Inflammatory Bowel Disease","author":"Burisch","year":"2015"},{"key":"2025021912242247100_CIT0002","doi-asserted-by":"crossref","first-page":"e386","DOI":"10.1016\/j.crohns.2013.03.001","article-title":"An exploration of the follow-up up needs of patients with inflammatory bowel disease","volume":"7","author":"Kemp","year":"2013","journal-title":"J Crohns Colitis"},{"key":"2025021912242247100_CIT0003","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/MOG.0000000000000653","article-title":"The treatment approach to inflammatory bowel disease in 2020","volume":"36","author":"Vachon","year":"2020","journal-title":"Curr Opin Gastroenterol"},{"key":"2025021912242247100_CIT0004","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.gastrohep.2020.06.032","article-title":"Treat-to-target approach in the management of inflammatory bowel disease","volume":"44","author":"Nu\u00f1ez","year":"2021","journal-title":"Gastroenterol Hepatol"},{"key":"2025021912242247100_CIT0005","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S2468-1253(23)00003-1","article-title":"The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission","volume":"8","author":"Burisch","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025021912242247100_CIT0006","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/ibd\/izz265","article-title":"Cost burden of Crohn\u2019s disease and ulcerative colitis in the 10-year period before diagnosis\u2014a Danish register-based study from 2003-2015","volume":"26","author":"Vadstrup","year":"2020","journal-title":"Inflamm Bowel Dis"},{"key":"2025021912242247100_CIT0007","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/ecco-jcc\/jjac138","article-title":"The incidence and prevalence of paediatric- and adult-onset inflammatory bowel disease in Denmark during a 37-year period: a nationwide cohort study (1980-2017)","volume":"17","author":"Dorn-Rasmussen","year":"2023","journal-title":"J Crohns Colitis"},{"key":"2025021912242247100_CIT0008","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41575-020-00360-x","article-title":"The four epidemiological stages in the global evolution of inflammatory bowel disease","volume":"18","author":"Kaplan","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2025021912242247100_CIT0009","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/apt.17145","article-title":"Therapeutic management and outcomes in inflammatory bowel diseases, 2010 to 2017 in cohorts from Denmark, Sweden and Norway","volume":"56","author":"Zhao","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"2025021912242247100_CIT0010","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1093\/ecco-jcc\/jjad075","article-title":"Management of inflammatory bowel disease using e-health technologies: a systematic review and meta-analysis","volume":"17","author":"Kuriakose Kuzhiyanjal","year":"2023","journal-title":"J Crohns Colitis"},{"key":"2025021912242247100_CIT0011","first-page":"CD014821","article-title":"Remote care through telehealth for people with inflammatory bowel disease","volume":"5","author":"Gordon","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"2025021912242247100_CIT0012","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0140-6736(17)31327-2","article-title":"Telemedicine for management of inflammatory bowel disease (MyIBDCoach): a pragmatic, multicentre, randomised controlled trial","volume":"390","author":"de Jong","year":"2017","journal-title":"Lancet"},{"key":"2025021912242247100_CIT0013","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/j.cgh.2020.04.038","article-title":"Cost-effectiveness of telemedicine-directed specialized vs standard care for patients with inflammatory bowel diseases in a randomized trial","volume":"18","author":"de Jong","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025021912242247100_CIT0014","doi-asserted-by":"crossref","first-page":"e15505","DOI":"10.2196\/15505","article-title":"Telemonitoring of Crohn\u2019s Disease and Ulcerative Colitis (TECCU): cost-effectiveness analysis","volume":"21","author":"Del Hoyo","year":"2019","journal-title":"J Med Internet Res"},{"key":"2025021912242247100_CIT0015","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.cct.2015.03.006","article-title":"TELEmedicine for Patients with Inflammatory Bowel Disease (TELE-IBD): design and implementation of randomized clinical trial","volume":"42","author":"Cross","year":"2015","journal-title":"Contemp Clin Trials"},{"key":"2025021912242247100_CIT0016","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/00365521.2020.1854342","article-title":"Self-monitoring with home based fecal calprotectin is associated with increased medical treatment. A randomized controlled trial on patients with inflammatory bowel disease","volume":"56","author":"\u00d6stlund","year":"2021","journal-title":"Scand J Gastroenterol"},{"key":"2025021912242247100_CIT0017","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1136\/gut.2010.220160","article-title":"E-health empowers patients with ulcerative colitis: a randomised controlled trial of the web-guided \u2018Constant-Care\u2019 approach","volume":"59","author":"Elkjaer","year":"2010","journal-title":"Gut"},{"key":"2025021912242247100_CIT0018","first-page":"B4478","article-title":"E-health: web-guided therapy and disease self-management in ulcerative colitis. Impact on disease outcome, quality of life and compliance","volume":"59","author":"Elkjaer","year":"2012","journal-title":"Dan Med J"},{"key":"2025021912242247100_CIT0019","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/MIB.0000000000001170","article-title":"Self-managed eHealth disease monitoring in children and adolescents with inflammatory bowel disease: a randomized controlled trial","volume":"23","author":"Carlsen","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"2025021912242247100_CIT0020","doi-asserted-by":"crossref","first-page":"6158","DOI":"10.3748\/wjg.v25.i40.6158","article-title":"Individualized home-monitoring of disease activity in adult patients with inflammatory bowel disease can be recommended in clinical practice: a randomized-clinical trial","volume":"25","author":"Ankersen","year":"2019","journal-title":"World J Gastroenterol"},{"key":"2025021912242247100_CIT0021","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1080\/00365521.2021.1892176","article-title":"Costs of electronic health vs. standard care management of inflammatory bowel disease across three years of follow-up\u2014a Danish register-based study","volume":"56","author":"Ankersen","year":"2021","journal-title":"Scand J Gastroenterol"},{"key":"2025021912242247100_CIT0022","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1111\/imj.15132","article-title":"E-Health and remote management of patients with inflammatory bowel disease: lessons from Denmark in a time of need.","volume":"51","author":"Ankersen","year":"2021","journal-title":"Intern Med J"},{"key":"2025021912242247100_CIT0023","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/CLEP.S91125","article-title":"The Danish National Patient Registry: a review of content, data quality, and research potential","volume":"7","author":"Schmidt","year":"2015","journal-title":"Clin Epidemiol"},{"key":"2025021912242247100_CIT0024","doi-asserted-by":"crossref","first-page":"607","DOI":"10.2147\/CLEP.S99478","article-title":"The Danish National Registry for biological therapy in inflammatory bowel disease","volume":"8","author":"Larsen","year":"2016","journal-title":"Clin Epidemiol"},{"key":"2025021912242247100_CIT0025","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/1403494810394718","article-title":"The Danish National Health Service Register","volume":"39","author":"Andersen","year":"2011","journal-title":"Scand J Public Health"},{"key":"2025021912242247100_CIT0026","author":"DLI","journal-title":"Danish Pharmaceutical Information"},{"key":"2025021912242247100_CIT0027","author":"Danish Medicine Agency","journal-title":"General Reimbursement of Medicines"},{"key":"2025021912242247100_CIT0028","author":"Danish Medical Council"},{"key":"2025021912242247100_CIT0029","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/1403494810394717","article-title":"The Danish National Prescription Registry","volume":"39","author":"Kildemoes","year":"2011","journal-title":"Scand J Public Health"},{"key":"2025021912242247100_CIT0030","author":"Statistics Denmark","journal-title":"Table LONS40."},{"key":"2025021912242247100_CIT0031","author":"Statistics Denmark","journal-title":"Table AKU502"},{"key":"2025021912242247100_CIT0032","author":"AMGROS","journal-title":"Guidelines for Cost Analyses of New Medicines and Indications in the Hospital Sector: Ver. 1.4"},{"key":"2025021912242247100_CIT0033","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/1403494811405098","article-title":"Danish registers on personal income and transfer payments","volume":"39","author":"Baadsgaard","year":"2011","journal-title":"Scand J Public Health"},{"key":"2025021912242247100_CIT0034","first-page":"1571","article-title":"The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn\u2019s Relapse Prevention Trial","volume":"91","author":"Irvine","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"2025021912242247100_CIT0035","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/gut.43.1.29","article-title":"A Simple Clinical Colitis Activity Index","volume":"43","author":"Walmsley","year":"1998","journal-title":"Gut"},{"key":"2025021912242247100_CIT0036","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(80)92767-1","article-title":"A simple index of Crohn\u2019s-disease activity","volume":"1","author":"Harvey","year":"1980","journal-title":"Lancet"},{"key":"2025021912242247100_CIT0037","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/MIB.0000000000001033","article-title":"Development of the IBD disk: a visual self-administered tool for assessing disability in inflammatory bowel diseases","volume":"23","author":"Ghosh","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"2025021912242247100_CIT0038","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/ibd\/izaa056","article-title":"Utility of the MARS-5 in assessing medication adherence in IBD","volume":"27","author":"Stone","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"2025021912242247100_CIT0039","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1016\/S0140-6736(17)32641-7","article-title":"Effect of tight control management on Crohn\u2019s disease (CALM): a multicentre, randomised, controlled phase 3 trial [published correction appears in Lancet 2018 Dec 23;390(10114):2768]","volume":"390","author":"Colombel","year":"2017","journal-title":"Lancet"},{"key":"2025021912242247100_CIT0040","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/s41395-018-0272-8","article-title":"A randomized controlled trial of TELEmedicine for patients with Inflammatory Bowel Disease (TELE-IBD)","volume":"114","author":"Cross","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"2025021912242247100_CIT0041","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/ibd\/izac134","article-title":"Trends in medical management of moderately to severely active ulcerative colitis: a nationwide retrospective analysis","volume":"29","author":"Yuan","year":"2023","journal-title":"Inflamm Bowel Dis"},{"key":"2025021912242247100_CIT0042","author":"Danish Society for Gastroenterology and Hepatology"},{"key":"2025021912242247100_CIT0043","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1080\/00365521.2021.1897670","article-title":"Increased use of biologics in the era of TNF-\u03b1 inhibitors did not reduce surgical rate but prolonged the time from diagnosis to first time intestinal resection among patients with Crohn\u2019s disease and ulcerative colitis\u2014a Danish register-based study from 2003-2016","volume":"56","author":"Qvist","year":"2021","journal-title":"Scand J Gastroenterol"},{"key":"2025021912242247100_CIT0044","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/apt.13971","article-title":"The incidence of inflammatory bowel disease in Denmark 1980-2013: a nationwide cohort study","volume":"45","author":"Lophaven","year":"2017","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/advance-article-pdf\/doi\/10.1093\/ecco-jcc\/jjae120\/58998404\/jjae120.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/19\/2\/jjae120\/58998404\/jjae120.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/19\/2\/jjae120\/58998404\/jjae120.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T12:24:54Z","timestamp":1739967894000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article\/doi\/10.1093\/ecco-jcc\/jjae120\/7729043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,7]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2,4]]}},"URL":"https:\/\/doi.org\/10.1093\/ecco-jcc\/jjae120","relation":{},"ISSN":["1873-9946","1876-4479"],"issn-type":[{"value":"1873-9946","type":"print"},{"value":"1876-4479","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,2]]},"published":{"date-parts":[[2024,8,7]]},"article-number":"jjae120"}}